Piper Sandler reveals its top 3 biotech stock picks for 2024

"After another difficult year, there are signs that biotech is recovering into 2024," the investment bank says, citing the prospect of interest rate cuts.

Related Keywords

Edward Tenthoff ,Johnson Janssen ,Piper Sandler ,Thad Barney ,Alnylam Pharmaceuticals Shares In ,Arrowhead Pharmaceuticals ,Alnylam Pharmaceuticals ,Arrowhead Pharmaceuticals Piper Sandler ,Novartis ,Pharmaceuticals Piper Sandler ,Arrowhead Pharmaceuticals Year To Date ,Biotech Legend ,Legend Biotech Year To Date ,Legend Biotech ,Pharmaceuticals Alnylam ,Alnylam Pharmaceuticals Shares ,Arrowhead Pharmaceuticals Inc ,Legend Biotech Corp ,Alnylam Pharmaceuticals Inc ,Johnson Amp ,Piper Jaffray Companies ,Environment ,Business News ,